ArticlePloS one2024

Nirmatrelvir/ritonavir or Molnupiravir for treatment of non-hospitalized patients with COVID-19 at risk of disease progression.

Adeel Ajwad Butt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.